Skip to content
Wenlo
Sign in
← Markets

Nektar Therapeutics

Nektar Therapeutics (NKTR) — Form 144: Proposed sale of shares

144NKTRFiled Nov 17, 2026, 10:57 AM ET

About this filing

Nektar Therapeutics (NKTR) filed Form 144 (proposed sale of shares) with the SEC on Nov 17, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.

Key facts

Seller
ROBIN HOWARD W
Relationship
Officer, Director
Shares to sell
429
Market value
$15,378.49
Approximate sale date
Nov 17, 2026
Broker
Fidelity Brokerage Services LLC
Acquired
Nov 13, 2026 · Restricted Stock Vesting
Remarks
  1. Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

More NKTR filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.